© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Back in the early 1980s, the search for potent veterinary antibiotics led researchers down the macrolide avenue. Tilmicosin came out of chemists' fascination with modifying known macrolides to make them work better in the lungs of livestock. After figuring out that certain substitutions, especially at the 16-position of the macrolide ring, could deliver long-lasting effects and better reach infection hotspots, scientists zeroed in on the tilmicosin molecule. Getting regulatory clearance was not easy—every country scrutinized residue levels in food-producing animals and insisted on proof of substantial respiratory pathogen knockout. Uptake was swift after registration, mostly through feed or water routes in cattle and swine. Since then, the market has widened, thanks to persistent respiratory disease problems on large-scale farms.
Tilmicosin phosphate commonly appears as a slightly yellow, free-flowing powder with a faint characteristic odor. In practice, this macrolide gets blended into feed premixes or solutions formulated for easy dispersion. Dose forms make use of its water solubility for mixing into drinking systems in barns. One vital thing stands out: its spectrum mainly covers Gram-positive bacteria and select important Gram-negative organisms—think *Mycoplasma*, *Pasteurella*, and *Mannheimia*. Its design leans on once-daily administration, easing up labor for animal caretakers and cutting stress on entire herds or flocks.
Pure tilmicosin phosphate carries the molecular formula C46H80N2O13•H3PO4, clocking in at a molecular weight close to 967.12. Most folks will recognize its powdery, pale yellow appearance. What sets it apart in the macrolide family is its high lipid solubility combined with phosphate salt formation, delivering better water stability. It thrives at room temperature storage without caking. Its melting point lands around 170°C, and it dissolves well in methanol and ethanol. pH matters—solutions generally keep stable between 4.0 and 8.0, avoiding degradation that saps potency. Most systems track purity above 95%, taking chromatographic fingerprints to catch trace impurities and confirm absence of related macrolides.
Labels on bulk tilmicosin phosphate require clear batch numbers, expiry dates, and storage advice—keep it dry, away from sunlight, never next to foodstuffs. Typical specifications set tilmicosin content at not less than 90.0% and not more than 105.0%, offering veterinarians assurance of dosing precision. Moisture content rarely exceeds 5%. Many markets enforce strict thresholds for heavy metals and residual solvents; arsenic and lead sit below 3 ppm and 5 ppm, respectively. Microbiological standards demand negligible total plate counts and the absence of pathogens. Directions tell users: don gloves, use dust masks, and wash hands after handling. Every bag or drum comes emblazoned with hazard statements warning of the risks to humans and non-target animals.
Production of tilmicosin phosphate starts with the synthesis of tylosin, another well-known macrolide, by fermentation using *Streptomyces fradiae*. Chemists then modify this tylosin core, specifically at the 4″-position, using chemical reagents to install the 3,5-dimethylpiperidinyl substituent. The resulting tilmicosin free base meets phosphoric acid to form the phosphate salt. Post-reaction purification scrubs unwanted byproducts through crystallization or solvent extraction, then drying and sieving yield a stable formulation ready for blending. Each cycle demands close monitoring; small deviations in temperature, reagent concentrations, or agitation can undermine purity.
Tilmicosin’s backbone, the 16-membered lactone, gets shaped by a set of methylations and amination steps post-fermentation. During its transformation from tylosin, the addition of the piperidinyl group at the desosamine sugar side chain dramatically shifts its tissue penetration and half-life in animal bodies. Phosphate formation anchors the molecule, resisting acid hydrolysis and breaking down more slowly in the harsh gut conditions of ruminants. Those seeking next-generation macrolides run small side-chain tweaks and substitutions, trying to dodge resistance mechanisms and boost potency. Any slight misstep in synthetic scale-up skips ahead to analytical testing—chromatography, NMR, and mass spectroscopy validate each batch, logging every reaction’s success or quirks along the way.
Veterinary supply markets recognize tilmicosin phosphate under a slew of names: Pulmotil, Tilmovet, Tilmicosin Premix, and simply Tilmicosin 20% or 25% Premix for feed formulations. The IUPAC name rarely appears on drug labels, but its synonyms—including 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)tylosin phosphate—frequently pop up in registration dossiers and academic papers. Local distributors sometimes swap in brand names, sowing confusion unless the label tightly matches international drug codes. Regulatory documents also demand the correct CAS number (137330-13-3 for the phosphate salt).
Field experience makes clear that tilmicosin phosphate’s benefits come with serious safety considerations. Mixing rooms require robust ventilation to limit powder inhalation. Staff must keep the compound out of reach from unauthorized personnel, double-check dosing by weight, and contain spills with designated neutral absorbents. No one takes chances with tilmicosin around. It proves fatal to humans at very low doses when injected—a risk underlined by multiple reported poisonings among veterinary staff. Strict lock-and-key storage, employee health monitoring, and detox protocols for accidental exposure all form part of operational routines. Agencies like the FDA and EMA demand complete traceability from manufacturing batch to end user, right down to returns and destruction logs for expired product.
Modern animal agriculture faces relentless battles against respiratory bacterial disease. Outbreaks threaten everything from commercial broiler chickens to beef cattle fattened for slaughter. In-feed and in-water tilmicosin solutions target group treatment—catching disease at onset, reducing losses, and smoothing out animal growth. Its action against *Pasteurella multocida,* *Mannheimia haemolytica*, and *Mycoplasma* species keeps it high on preferred drug lists wherever respiratory disease pressure rages. Swine production draws on tilmicosin to suppress *Actinobacillus pleuropneumoniae* and control outbreaks that can wreck entire barns. The prospect of fewer injections means less handling, better animal welfare, and real labor savings.
Scientists in the macrolide field keep racing to boost something that’s worked so well for decades. Every few years, academic groups and pharma companies lay out fresh formulations—slow-release granules, dispersible tablets, and nanoparticle suspensions—chasing more convenient delivery systems. There’s a push to tweak the molecule for lower environmental residue, greater pathogen selectivity, and lower cross-resistance. Researchers pore over microbiome impacts, tracking shifts in gut flora from prolonged exposure. The research trickles down into on-farm trials, where vets track any hint of resistance, dosing failures, or emerging off-target effects. With increasing pressure from regulatory agencies to trim down routine antibiotic use, the R&D world balances the search for new claims against society's demand for less farm-level drug reliance.
Examples from clinical reports drive home tilmicosin phosphate’s toxicity concerns. Ingestion or accidental injection by humans leads to cardiovascular collapse—fatal in less than one hour at surprisingly low exposure. Toxicology studies in lab animals reinforce the risk: doses far above therapeutic levels wreck heart muscle, sink blood pressure, and crunch bone marrow. Animal welfare risk sits highest for goats and rabbits—minor dosing errors can prove catastrophic. Residue tests enforce careful withdrawal periods in meat and milk, blocking contaminated product from entering the food chain. Environmental studies check runoff and manure for tilmicosin residues, probing threats to aquatic ecosystems and downstream antibiotic resistance spread.
Antimicrobial stewardship keeps tightening with each passing year, shaping the discussion around tilmicosin phosphate use. There’s an unmistakable shift toward precision dosing, improved diagnostics, and alternatives such as vaccines, probiotics, and immune stimulants. Governments and private industry both chase better surveillance for resistance, routine batch testing, and residue monitoring at slaughter. While tilmicosin continues filling a needed niche in intensive agriculture, researchers gaze past routine group treatment, investing in next-generation macrolides that dodge resistance and cut environmental persistence. The future looks set to reward those manufacturers who invest in transparency, safety innovations, and a willingness to support farmers in disease reduction—not just drug dispensing. This means the growth of tilmicosin phosphate remains tied to ongoing investment in safer processes, smarter dosing systems, and a focus on animal and human safety above all.
People ask about Tilmicosin Phosphate all the time, especially at cattle barns and poultry houses. This stuff plays a key role in keeping animals healthy—specifically, it’s a macrolide antibiotic used to fight some nasty bacterial infections in farm animals like cattle, pigs, and chickens. Respiratory disease poses one of the biggest headaches for those who raise livestock. Coughing calves, runny-nosed feeders, hogs losing their appetite—any of these problems can slam a farm’s finances pretty hard. When veterinarians pull out Tilmicosin Phosphate, they’re aiming to stop these outbreaks fast, especially infections caused by bugs like Pasteurella, Mannheimia, and Mycoplasma.
Tilmicosin Phosphate isn’t just another medicine on the shelf. Talking to ranchers at auctions, it’s clear that losing even a handful of animals to pneumonia or other respiratory problems digs a real hole. The guilt hits hard, too; farmers care for their herds. Respiratory infections can turn healthy feeders into downed, unthrifty cattle in just a few days. For folks raising poultry, outbreaks spread so quick that the sound of sick birds or the sight of swollen faces sparks anxiety.
Fieldwork and published research both show that timely treatment with Tilmicosin knocks these infections back and keeps mortality in check. Farms that manage these health challenges see more consistent weight gains, steadier feed intake, and fewer setbacks. Healthy animals are more productive, so health solutions like Tilmicosin can tip the balance between a profitable year and a tough one.
Farm productivity ties directly to food prices and quality at the grocery store. If infectious disease sweeps through livestock herds uncontrolled, the chain of losses moves from rural towns to urban markets. Rising costs, supply shortages, or poorer-quality meat and eggs can follow. Responsible antibiotic use helps keep barns full and shelves stocked. Products like Tilmicosin have formed a mainstay in this battle, according to years of studies by agriculture colleges and federal vets.
Even a good thing carries risks. I remember heated speeches at extension meetings and industry roundtables about antibiotic resistance. More people want to know what’s entering the food supply. That’s why doctors and regulators stress the importance of only using medicines like Tilmicosin when necessary, not as a routine crutch. Laws now require veterinarians to authorize its use and to follow withdrawal times so that no unsafe residues end up in meat or milk.
Producers face pressure to try vaccines, better ventilation, and improved biosecurity before reaching for antibiotics. Some operations have adopted these steps, reporting fewer disease outbreaks over time. Developing new, fast diagnostic tools also helps catch illness at an early stage, so targeted treatments become possible. These changes take both time and investment, but the goal of protecting animal health while safeguarding public trust drives these efforts.
Keeping animals healthy and farm operations running smoothly challenges everyone from ranch hands to researchers. Tilmicosin Phosphate remains an important tool, especially against respiratory disease. As more is learned about animal care and disease prevention, solutions will keep evolving. For now, trust and education between farmers, vets, and consumers drives better choices. Every dose given with care supports that bigger goal.
Tilmicosin Phosphate matters in the world of livestock health. As a veterinarian who has spent years treating cattle and sheep, I’ve seen firsthand how respiratory disease sweeps through herds. Producers count on this macrolide antibiotic to target Pasteurella and Mannheimia, cutting down on losses and bringing animals back from the brink. Knowing how to give this medicine safely changes everything—from treatment success rates to animal welfare and, yes, even food safety.
Oral administration stands out. In feedlots and sheep barns, mixing Tilmicosin Phosphate with feed or water offers simplicity. Cost-effective for large groups, this method fits well on farms where catching and restraining animals creates stress for everyone involved. Dosing by feed or water only makes sense when you weigh animals and measure feed intake. Too little, and infection lingers. Too much, and health risks soar. The U.S. Food and Drug Administration (FDA) and European Medicines Agency both stress proper calculation and monitoring.
Direct oral dosing by drenching or gavage sits on the table for smaller herds or severe cases. Each animal gets a measured dose, which minimizes waste and overdosing. The downside? Labor increases, and untrained handlers may injure animals if care slips. In practice, I’ve only recommended drenching during outbreaks or for high-value animals.
Injection deserves special mention, since Tilmicosin via subcutaneous injection delivers medicine straight to the bloodstream. Only trained professionals should hold this syringe. Accidental self-injection for humans proves life-threatening. Hundreds of reports back this up. Some clinics keep calcium gluconate on hand, but prevention through rigorous safety protocols keeps teams safe. Regulatory bodies warn producers year after year: never use tilmicosin shots without proper training.
Gloves, masks, and long sleeves offer frontline defense for workers. I’ve seen farmers ignore these steps, only to suffer rashes or worse. Materials should be disposed of in hazardous waste bins. Residue in the environment can fuel antimicrobial resistance, which endangers public health. Proper clean-up after mixing Tilmicosin Phosphate—whether for feed or water—cuts down on these dangers. Runoff from livestock operations carries antibiotic traces into soil and groundwater. Science journals show resistant bacteria can develop as a result. Responsible handling protects not just the herd, but the whole community.
Responsible dosing starts with accurate weights. Guesswork leads to dosing errors, which wastes money and risks resistance. Calibrated feeders help, but nothing replaces regular scale checks. Training employees pays off over the long run: fewer mistakes, smoother operations, and better animal outcomes.
Checking withdrawal times before slaughter safeguards public health by keeping drug residues out of the food chain. Government agencies regularly update these times. As a vet, I always keep the latest charts taped to the medicine cabinet. Build that habit and regulatory headaches shrink. Open communication with feed mill partners and veterinarians ensures mistakes get caught quickly. If doubt creeps in, call for help rather than risk an error with serious consequences.
Antibiotic stewardship can’t be a buzzword. Producers, veterinarians, and regulators share this responsibility. Using Tilmicosin Phosphate wisely preserves its power for future generations and maintains trust in the foods landing on our tables.
Tilmicosin phosphate shows up often in animal health, especially in livestock. It's an antibiotic that tackles respiratory infections, mainly in cattle and pigs. Farmers count on it to limit economic loss from sick animals. Every veterinarian I’ve known keeps it in their toolbox for tough cases of pneumonia. By fighting bacteria like Mannheimia haemolytica and Pasteurella multocida, tilmicosin phosphate helps herds recover faster and keeps large-scale farms running. Yet, knowing what risks might follow after its use builds real trust between vets and farmers. That’s always stuck with me, long after watching cattle bounce back or hearing a producer’s relief after a bad outbreak turns around.
Side effects pop up sometimes, even if used exactly as prescribed. At lower doses, animals might stop eating or seem a bit off. Some develop swelling at the injection site, and I’ve watched livestock limp or lose hair where they got their shot. I once saw a cow’s appetite tank for a couple days after treatment, which rang alarm bells, so close monitoring always made sense to me. These aren’t rare; manufacturers even note the risk right in the product sheets.
Things get serious if dose calculations go wrong. Overdosing causes heart troubles—some animals collapse or die suddenly. In pigs, even a small misstep leads to breathing problems, irregular heart rates, or trembling. Precise weights, not guesses, make all the difference for safety. Years ago, a neighbor rushed to call the vet after a piglet started gasping just after a miscalculated dose. Quick action made all the difference, but stories like these show the need for caution.
Tilmicosin phosphate won’t just hurt animals if misused. Human contact with the drug during mixing or injection becomes dangerous, especially by accidental injection. Studies show this compound can trigger severe heart problems in people, sometimes fatally. Medical journals detail emergency hospitalizations from accidental needlesticks. Every vet I’ve asked handles it with gloves and shields, and keeps an antidote kit handy, just in case. Training and awareness cut down on hospital visits and help keep everyone on the farm safe.
Every antibiotic carries the risk of breeding resistant bacteria. Tilmicosin phosphate stands in the same crowd. Using it too freely — for mild coughs or without testing for bacteria—gives bacteria more time to learn how to resist it. I learned early on—mostly from hearing hard stories in vet clinics—that preventable mistakes in dosing or over-prescribing make life a lot harder down the road. In Canada and the US, more oversight makes a real difference. Prescription rules, surveillance, and routine lab tests help limit unnecessary use.
Best safety starts with careful dosing and clear communication. Always give exact weight-based doses, monitor animals post-treatment, and stick to withdrawal times for food production. Use personal protective equipment every time. Periodic reviews about what drugs work and open conversations between labs, government, and producers keep antibiotics effective for longer. Awareness on the ground keeps everyone—animals and people—out of avoidable emergencies.
Tilmicosin phosphate shows up most often in the livestock world, where farmers and veterinarians use it to tackle tough respiratory infections in cattle, sheep, and pigs. As someone who grew up around family-owned dairy farms, I’ve watched veterinarians handle treatments like tilmicosin with care, keeping an eye on dosages and the well-being of the entire herd. Folks depend on veterinarians for good reason — misusing antibiotics can ripple through the food system and harm both animals and humans.
Right now, selling tilmicosin phosphate without a veterinarian’s oversight can lead to serious trouble. The reason: tilmicosin is strong. If you mix up the dose or handle it wrong, animals might not get better, or worse, they could suffer harmful effects. Tilmicosin isn’t an everyday medicine you find at the corner store. It’s produced by companies that emphasize veterinarian-only sales for a reason. Safety warnings for people aren’t just legal fine print. Accidental self-injection in humans can cause dangerous heart rhythm changes, even death. This isn’t fear mongering — there have been published medical cases. That’s one reason why you can’t just walk into a feed shop and buy tilmicosin like you’d buy fencing wire or hay bales.
Resistance builds up when antibiotics get used without good guidance. For tilmicosin, which fights respiratory infections, resistance in bacteria like Mannheimia haemolytica challenges both the farming and veterinary fields. If resistance spreads, standard treatments might stop working and farms could lose a valuable lifeline. The FDA in the U.S. treats tilmicosin-containing products as prescription-only. In Europe and many parts of Asia, national rules also block sale without veterinary oversight. This global alignment shows a shared concern: protect animals, safeguard humans, and keep antibiotics effective for as long as possible.
I’ve watched neighbors scramble to treat sick cattle with over-the-counter products, sometimes with more harm than good. It takes skill to diagnose a respiratory illness correctly. Some infections might look the same but call for different drugs. A wrong guess wastes time and puts the whole herd at risk. When veterinarians write prescriptions for tilmicosin, they’re not just following red tape — they’re making sure the farm stays healthy with the right product, dose, and treatment length.
Stewardship goes hand-in-hand with access. On busy farms, time matters, and waiting for paperwork slows things down. More digital tools connect veterinarians and farmers to speed up the process, so animals get help faster while safety stays front and center. Making sure every prescription flows from a real need — and not habit or convenience — will help keep antibiotics working. That’s something both veterinarians and farmers support.
No one enjoys more regulation, least of all veterinarians who work long days in tough weather. Still, a prescription requirement for drugs like tilmicosin reminds us that some medicines aren’t simple fixes. They call for expertise and a steady hand. Every farm visit, every sick animal, and every vet’s signature builds toward a system where animals get better, people stay protected, and tomorrow’s medicines have a fighting chance.
Tilmicosin Phosphate has a slot in the world of veterinary antibiotics, and it's not just another name in the medicine cabinet. This macrolide, developed with a careful eye on livestock needs, was made for a focused group. Cattle, swine, sheep, and sometimes poultry—these are the animals that see the green light for tilmicosin. Each type brings unique challenges, but infectious disease is one concern they share. Farmers face respiratory problems in their herds more often than many city folks might think, especially where animals are raised closely together. Tilmicosin’s strength targets these respiratory outbreaks. That pursuit for healthy herds keeps it in steady demand across large-scale farms.
Some treatments suit only certain species, and tilmicosin’s profile proves no exception. In beef and dairy cattle, veterinarians rely on it to take down pathogens like Mannheimia haemolytica, a big cause of bovine respiratory disease (BRD). I grew up around feedlots in the Midwest, watching neighbors lose a week’s worth of production to a simple cough that escalated. This kind of setback costs meat and milk, but also causes animal distress no good producer wants. Tilmicosin offers an answer when early action can keep herds healthy and productive.
The story sounds similar in pigs. Swine herds, especially young ones, often fall to Actinobacillus pleuropneumoniae and Pasteurella multocida. Both bacteria hit fast and hard. I remember one local hog farmer jotting down every case on a feed sack, worried about the whole barn. With FDA and EMA stamping approval, vets gained another tool to save animals and keep food supplies moving. In the US, tilmicosin is available via veterinary prescription, usually in injectable or feed-medication form.
In sheep, tilmicosin also has a place at the treatment table, focusing largely on the same respiratory bugs that endanger market lambs. Plenty of producers will say a ewe’s cough rarely stays small—these infections like to move in groups. Keeping tilmicosin limited to a clear list of animals matters because it keeps the antibiotic effective for those it is actually meant for—and lowers the risk for resistance spreading.
This isn’t just about solving animal illness. Regulatory authorities like the FDA and EMA sign off on tilmicosin uses after checking safety for human food. Drug residues in milk, meat, or eggs have to clear strict standards before those products land on your plate or mine. Withdrawal times after a course of antibiotics aren’t there just for paperwork—they mark the minimum window to make sure drug traces drop below risk levels. These measures protect people and keep export markets open for farmers who depend on global trade.
Getting approval for a specific list of animals isn’t just bureaucratic formality. Narrowing tilmicosin’s label to cattle, swine, and sheep means the industry avoids the temptations of off-label use in species where risks rise. During my visits with local vets, many talk about growing antibiotic resistance. The best answer, they say, is limiting powerful drugs to the areas that absolutely need them and keeping strict oversight. Education and farm management hold as much impact as any bottle from a vet’s bag. Clear recordkeeping, targeted prescriptions, and consistent review help build a future where both animal health and public health keep moving in the right direction.
| Names | |
| Preferred IUPAC name | (2R,3R,4R,5R,8R,10R,11R,12R,13S,14R)-5-(3,5-dimethylpiperidin-1-yl)-2-ethyl-14-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-7,9,13-trihydroxy-10,12-dimethoxy-3,5,7,9,11,13-hexamethyl-4,6,8,10,12,14-hexahydroxytetradecanal phosphate |
| Other names |
Til Phos Tilmicosin hydrogenphosphate Tilmicosin phosphate salt Tilmicosin H3PO4 Phosphoric acid tilmicosin salt |
| Pronunciation | /ˌtɪl.mɪˈkoʊ.sɪn ˈfɒs.feɪt/ |
| Identifiers | |
| CAS Number | 137330-13-3 |
| Beilstein Reference | **136859** |
| ChEBI | CHEBI:85274 |
| ChEMBL | CHEMBL1743028 |
| ChemSpider | 174780 |
| DrugBank | DB11418 |
| ECHA InfoCard | 100.233.622 |
| EC Number | Unassigned |
| Gmelin Reference | 8452384 |
| KEGG | C14416 |
| MeSH | D000071254 |
| PubChem CID | 133436258 |
| RTECS number | OI9621000 |
| UNII | 2L5N0JP7L9 |
| UN number | UN3249 |
| Properties | |
| Chemical formula | C46H81NO17P |
| Molar mass | 1215.45 g/mol |
| Appearance | White or almost white powder |
| Odor | Odorless |
| Density | D0.35-0.45g/cm³ |
| Solubility in water | Soluble in water |
| log P | -0.66 |
| Acidity (pKa) | 12.55 |
| Basicity (pKb) | 8.54 |
| Magnetic susceptibility (χ) | -75.9×10⁻⁶ cm³/mol |
| Dipole moment | 1.82 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 365.4 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | QJ01FA91 |
| Hazards | |
| Main hazards | May be fatal if swallowed, inhaled, or absorbed through skin. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07,GHS09 |
| Signal word | Danger |
| Hazard statements | H302 + H332: Harmful if swallowed or if inhaled. |
| Precautionary statements | P260, P262, P263, P264, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P312, P314, P321, P332+P313, P337+P313, P363, P403+P233, P405, P501 |
| NFPA 704 (fire diamond) | 2-3-2-X |
| Flash point | >100°C |
| Lethal dose or concentration | LD₅₀ Oral Rat: 2,140 mg/kg |
| LD50 (median dose) | LD50 (oral, rat): 855 mg/kg |
| NIOSH | NAERG: 151 |
| PEL (Permissible) | PEL: Not established |
| REL (Recommended) | Oral: 15-20 mg/kg bw |
| Related compounds | |
| Related compounds |
Tilmicosin Tulathromycin Tylosin Tiamulin Spiramycin |
